Trial Profile
Flu-Like Symptoms as a Complication of Botulinum Toxin Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2017
Price :
$35
*
At a glance
- Drugs Botulinum toxin B (Primary) ; Botulinum-Toxin-A (Primary)
- Indications Drug-induced dyskinesia; Dystonia; Myoclonus; Tic disorders; Tremor
- Focus Adverse reactions; Biomarker
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Apr 2011 New trial record